Cargando…
Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene
β-Thalassaemia is caused by over 300 mutations in and around the β-globin gene that lead to impaired synthesis of β-globin. The expression of α-globin continues normally, resulting in an excess of α-globin chains within red blood cells and their precursors. These unpaired α-globin chains form unstab...
Autor principal: | Mettananda, Sachith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525347/ https://www.ncbi.nlm.nih.gov/pubmed/34713267 http://dx.doi.org/10.3389/fgeed.2021.752278 |
Ejemplares similares
-
Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia
por: Mettananda, Sachith, et al.
Publicado: (2019) -
Recent Approaches for Manipulating Globin Gene Expression in Treating Hemoglobinopathies
por: Mussolino, Claudio, et al.
Publicado: (2021) -
Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study
por: Mettananda, Sachith, et al.
Publicado: (2019) -
Anaemia among females in child-bearing age: Relative contributions, effects and interactions of α- and β-thalassaemia
por: Mettananda, Sachith, et al.
Publicado: (2018) -
Psychological morbidity among children with transfusion dependent β-thalassaemia and their parents in Sri Lanka
por: Mettananda, Sachith, et al.
Publicado: (2020)